Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

PURPOSE: Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for their propensity to metastasize and comparatively favorable prognosis. Although both the treatment options and clinical outcomes have improved in the last decades, most patients will die of metastatic disease. New...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Scott, Aaron T., Weitz, Michelle, Breheny, Patrick J., Ear, Po Hien, Darbro, Benjamin W., Brown, Bart J., Braun, Terry A., Li, Guiying, Umesalma, Shaikamjad, Kaemmer, Courtney, Maharjan, Chandra Kumar, Quelle, Dawn E., Bellizzi, Andrew M., Chandrasekharan, Chandrikha, Dillon, Joseph S., O’Dorisio, Thomas M., Howe, James R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7165057/
https://ncbi.nlm.nih.gov/pubmed/31937620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2884
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados